State House panel votes to ease drug licensing
Legislation making drug licensing easier for pharmaceutical manufacturers was approved Tuesday by a House committee. The Health Committee voted unanimously for House Bill 2162 sponsored by Rep. Lisa Borowski, D-Delaware, creating a dual track for state and federal approval for new products. HB2162 enables a manufacturer to apply for a state license when they seek approval from the Federal Drug Administration (FDA) for a new drug. Currently, Pennsylvania requires pharmaceutical companies to obtain FDA approval before they apply for a state license. The FDA process takes longer than ...